Patterns of HIV care for patients with serious mental illness

AIDS Patient Care and STDs

Volumn 20, Issue 3, 2006, Pages 175-182

  Bogart, Laura M ^a   Fremont, Allen M ^a,b,c   Young, Alexander S ^a,b,c   Pantoja, Philip ^a   Chinman, Matthew ^a,b   Morton, Sally ^a   Koegel, Paul ^a   Sullivan, Greer ^a,d,e   Kanouse, David E ^a  

^a RAND CORPORATION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA South Central Mental Illness Research Education and Clinical Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH CARE DISTRIBUTION; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; PATIENT CARE; PATIENT MONITORING; UNITED STATES; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; QUALITY OF HEALTH CARE; SOCIAL CLASS; VIRAL LOAD;

EID: 33645359219     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.175     Document Type: Article

References (23)

1. Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: a critical review. Clin Psychol Rev 1997;17:259-269.
2. Gordon CM, Carey MP, Carey KB, Maisto SA, Weinhardt LS. Understanding HIV-related risk among persons with a severe and persistent mental illness: Insights from qualitative inquiry. J Nerv Ment Dis 1999;187:208-216.
3. McKinnon K, Cournos F. HIV infection linked to substance use among hospitalized patients with severe mental illness. Psychiatr Serv 1998;49:1269.
4. McKinnon K, Cournos F, Sugden R, Guido JR, Herman R. The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among people with severe mental illness. J Clin Psychiatry 1996;57:506-513.
5. Volavka J, Convit A, Czobor P, Douyon R, O'Donnell J, Ventura F. HIV seroprevalence and risk behaviors in psychiatric inpatients. Psychiatr Res 1991;39:109-114.
6. Sullivan G, Koegel P, Kanouse DE, et al. HIV and people with serious mental illness: The public sector's role in reducing HIV risk and improving care. Psychiatr Serv 1999;50:648-652.
7. Liebermann AA, Coburn AF. The health of the chronically mentally ill: A review of the literature. Commun Mental Health J 1986;22:104-116.
8. Bogart LM, Kelly JA, Catz SL, Sosman JM. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr 2000;23:396-404.
9. Andersen R, Bozzette S, Shapiro M, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study, Health Serv Res 2000;35:389-416.
10. Bing EG, Kilbourne AM, Brooks RA, Lazarus EF, Senak M. Protease inhibitor use among a community sample of people with HIV disease. J Acquir Immune Defic Syndr 1999;20:474-480.
11. Pulvirenti JJ, Glowacki R, Muppiddi U, et al. Hospitalized HIV-infected patients in the HAART era: A view from the inner city. AIDS Patient Care STDs 2003;17:565-573.
12. Young AS, Sullivan G, Bogart LM, Koegel P, Kanouse D. Needs for basic services among adults with severe mental illness and HIV. Psychiatr Serv 2005;56:99-101.
13. Dixon LB, Kreyenbuhl JA, Dickerson FB, et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illness. Psychiatr Serv 2004;55:892-900.
14. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. N Engl J Med 1998;339:1897-1904.
15. US Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Morb Motal Wkly Rep 1998;47:43-82.
16. Carpenter CC, Fischl MA, Hammer SM, et al. Anti-retroviral therapy for HIV infection in 1998: recommendations of the International AIDS Society-USA panel. JAMA 1998;280:78-86.
17. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1691.
18. Himelhoch S, Moore RD, Treisman G, Gebo KA. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004;37:1457-1463.
19. Katz MH, Cunningham WE, Mor V, et al. Prevalence and predictors of unmet need for supportive services among HIV-infected persons: Impact of case management. Med Care 2000;38:58-69.
20. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently-diagnosed HIV-infect persons to care. AIDS 2005;19:423-431.
21. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDs 2003;17:179-186.
22. Crystal S, Sambamoorthi U, Moynihan PJ, McSpiritt E. Initiation and continuation of newer antiretroviral treatments among Medicaid recipients with AIDS. J Gen Intern Med 2001;16:850-859.
23. Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health 2002;92:92-98.